Abingworth Revenue and Competitors
Estimated Revenue & Valuation
- Abingworth's estimated annual revenue is currently $6.8M per year.
- Abingworth's estimated revenue per employee is $113,100
Employee Data
- Abingworth has 60 Employees.
- Abingworth grew their employee count by 7% last year.
Abingworth's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Managing Partner, Chief Investment Officer | Reveal Email/Phone |
2 | Executive Assistant/Office Manager | Reveal Email/Phone |
3 | Operations Manager, US | Reveal Email/Phone |
4 | Principal | Reveal Email/Phone |
5 | Senior Investment Assistant | Reveal Email/Phone |
6 | Managing Partner, Head Life Sciences | Reveal Email/Phone |
7 | Executive Assistant | Reveal Email/Phone |
8 | Operations Support Specialist | Reveal Email/Phone |
9 | Receptionist and Team Assistant | Reveal Email/Phone |
Abingworth Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1770.7M | 9525 | 16% | $2.3B | N/A |
#2 | $21.6M | 151 | -3% | N/A | N/A |
#3 | $5.2M | 50 | 14% | N/A | N/A |
#4 | $5920M | 6292 | 0% | $552.3M | N/A |
#5 | $1M | 13 | -41% | N/A | N/A |
#6 | $6.4M | 55 | 8% | N/A | N/A |
#7 | $1.6M | 25 | -44% | $44M | N/A |
#8 | $1.4M | 21 | 0% | $4.7M | N/A |
#9 | $2.5M | 28 | -10% | N/A | N/A |
#10 | $3.5M | 34 | -6% | N/A | N/A |
What Is Abingworth?
Abingworth is a long-established venture capital firm specialising in unquoted and life science biomedical companies. With offices in London, Cambridge (UK) and Menlo Park, Abingworth is active on both sides of the Atlantic and, in the past fifteen years, has backed more than 80 developing life science/medical businesses. The majority of these have gone on to public offerings or have merged or been acquired by leading companies in the industry. Abingworth has funds under management of over $700 million.
keywords:N/A
N/A
Total Funding
60
Number of Employees
$6.8M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Abingworth News
Global investment firm Carlyle (Nasdaq: CG) announced today that it has agreed to acquire Abingworth, a transatlantic life sciences...
Carlyle has agreed to acquire Abingworth, a life sciences investment firm. No financial terms were disclosed. The deal is expected to close...
NEW YORK, NY Global investment firm Carlyle (NASDAQ: CG) announced today that it has agreed to acquire Abingworth, a transatlantic life...
Risk-sharing agreement with Abingworth will fund seladelpar Phase 3 development program for PBC CymaBay retains full worldwide commercial rights to seladelpar NEWARK, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company ...
Abingworth has raised $582 million for its second clinical co-development fund. The fund, ACCD 2, equips Abingworth to make triple-digit million investments in late-stage clinical programs. London-based Abingworth got into clinical co-development investing in 2009. Initially, Abingworth used mo ...
Other Companies in Menlo Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.3M | 60 | -10% | $25.7M |
#2 | $13.7M | 60 | -3% | N/A |
#3 | $9.9M | 61 | -5% | N/A |
#4 | $8.6M | 62 | 41% | N/A |
#5 | $8.4M | 64 | 14% | N/A |